Related Experiment Videos
[Multidisciplinary treatment for small cell lung cancer]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1984
Summary
Multidisciplinary treatment, including chemotherapy and radiation, shows promise for small cell lung cancer. Induction chemotherapy and subsequent radiation therapy yield significant response rates in both limited and extensive disease stages.
Area of Science:
- Oncology
- Pulmonology
- Medical Treatment
Context:
- Small cell lung cancer (SCLC) presents unique treatment challenges.
- Multidisciplinary approaches are crucial for optimizing patient outcomes.
- Understanding treatment efficacy across different disease stages is vital.
Purpose:
- To evaluate the effectiveness of a multidisciplinary treatment strategy for small cell lung cancer.
- To assess response rates to induction chemotherapy and subsequent radiation therapy.
- To determine the efficacy of different chemotherapeutic agents in non-responder and recurrent cases.
Summary:
- Induction chemotherapy demonstrated response rates of 69.2% in limited and 57.1% in extensive SCLC.
- Radiation therapy post-chemotherapy yielded response rates of 87.8% in limited and 58.3% in extensive disease.
- Epipodophyllotoxin and/or cisplatin were effective for non-responders/recurrent cases, unlike mitomycin C and/or adriamycin.
Impact:
- The study highlights the efficacy of combined modality treatment in SCLC.
- Median survival was 12.2+ months for all cases, with longer survival in limited disease.
- Findings support the use of specific chemotherapeutic agents in refractory SCLC cases.